Mario Sznol MD

Professor of Medicine (Medical Oncology); Clinical Research Program Leader, Melanoma Program, Yale Cancer Center; Co-Director, Yale SPORE in Skin Cancer

Departments & Organizations

Yale Medical GroupCancer Center, Yale: Prostate and Urologic Cancers Program; Melanoma Program; Cancer ImmunologyHTISPORE in Skin CancerMedical OncologyDevelopmental TherapeuticsGeneral Urology | Medical Oncology


Dr. Mario Sznol is Professor of Medicine (medical oncology) and Clinical Research Program Leader for the Melanoma Program. Dr. Sznol, formerly with the National Cancer Institute, has an international reputation in cancer drug development. Dr. Sznol's expertise and experience is in cancer immunotherapy, drug development for cancer, and treatment of patients with melanoma and renal cell carcinoma. He is working to expand the opportunities for clinical trials at the Yale Cancer Center, particularly those focusing on immunotherapy and novel agents.


  • B.A., Rice University , 1979
  • M.D., Baylor College of Medicine , 1982